RecruitingPhase 1 / Phase 2NCT07600983
17
studies recruiting now
as of 7 Sept 2026
414
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
2 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07621653
Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine] Administered in Participants Aged 6 Weeks to 55 Years in Republic of Korea
RecruitingPhase 3NCT07596199
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
RecruitingNCT07347938
A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
RecruitingPhase 4NCT07097012
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 17 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Tetanus study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Tetanus
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
5 approved treatments and 2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Bordetella Pertussis Pertactin Autotransporter (Bordetella pertussis pertactin autotransporter component of infanrix hepb)Approved: Hepatitis B Virus Hbsag Surface Protein Antigen (Ambirix)Approved: Diphtheria Toxoid (Diphtheria toxoid component of hexacima)Approved: Bordetella Pertussis Filamentous Hemagglutinin (Bordetella pertussis filamentous hemagglutinin component of hexacima)Approved: Tetanus Toxoid (Equilis te)
Phase 3Siltartoxatug
Phase 3Pertussis Vaccine
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).